Description |
high mobility group AT-hook 1 |
retinoic acid receptor gamma |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Adapalene
- Acitretin
- Alitretinoin
- Tretinoin
- Tazarotene
- Etretinate
- Isotretinoin
- SR11254
- BMS-181156
- CD564
- Dodecyl-Alpha-D-Maltoside
- BMS184394
- R667
- LGD-1550
- 3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid
- 3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid
- Trifarotene
|
Diseases |
|
|
GWAS |
|
- Anthracycline-induced cardiotoxicity in childhood cancer ( 26237429)
- Cardiorespiratory fitness (800m run time) ( 32572135)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
|
Interacting Genes |
64 interacting genes:
ANXA1
ANXA2
APEX1
APP
ATF2
CDK1
CEBPB
CREBBP
CSNK2A1
CSNK2A2
CWC27
DNAJC8
EIF2S2
ELF1
EWSR1
GTF2F2
HEMGN
HIPK2
HMGB1
HMGB2
HMGB3
HNRNPA1
HNRNPAB
HNRNPD
HNRNPDL
HNRNPL
HPF1
HSPA1A
IRF1
JUN
KAT2B
METAP2
NCL
NFKB1
NFYA
NPM1
OLA1
ORC6
PA2G4
PARP1
PCBP1
PCBP2
POU2F1
POU2F2
POU3F1
PPARG
PPP1R8
PRKCA
PRMT6
PSIP1
PTBP1
RARA
RARG
RCC1
RN7SK
RNF4
RXRA
SP1
SRF
SRPK2
SSB
SUFU
SYNCRIP
UPF2
|
35 interacting genes:
ACY3
ARID1A
BBS4
HMGA1
IL24
ITGB1BP2
LSR
MAP6
MRPL12
MTMR6
MYF5
NCOA1
NCOA3
NCOR1
NCOR2
NEK9
NKX3-1
NR0B2
NR2F6
OIP5
PNRC1
PNRC2
PRIM1
PRKAR1B
PSMC5
RHPN2
RXRA
RXRB
RXRG
S100A3
SMAD3
SMARCD3
SPHK1
TNIP1
ZNF576
|
Entrez ID |
3159 |
5916 |
HPRD ID |
02829 |
01573 |
Ensembl ID |
ENSG00000137309
|
ENSG00000172819
|
Uniprot IDs |
P17096
Q5T6U8
|
A8K3H3
B7Z4B4
F1D8P1
P13631
|
PDB IDs |
2EZD
2EZE
2EZF
2EZG
|
1EXA
1EXX
1FCX
1FCY
1FCZ
1FD0
2LBD
3LBD
4LBD
5M24
6FX0
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|